CORRECTION: RBC Capital Reiterates Outperform on Mirum Pharmaceuticals, Maintains $155 Price Target
Citizens Maintains Market Outperform on Mirum Pharmaceuticals, Raises Price Target to $167
HC Wainwright & Co. Maintains Buy on Mirum Pharmaceuticals, Raises Price Target to $202
Cantor Fitzgerald Maintains Overweight on Mirum Pharmaceuticals, Raises Price Target to $160
Mirum Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update
Loading...